Skip to main content
. Author manuscript; available in PMC: 2020 Aug 31.
Published in final edited form as: Cell Biol Toxicol. 2016 Mar 23;32(1):61–81. doi: 10.1007/s10565-016-9318-0

Fig. 6.

Fig. 6

Schematic representation of CBP and p300 and the high percentage of identity at the amino acid level between various regions of these large Kat3 coactivators, despite their divergence more than 450 million years ago. The very amino terminal of CBP, to which CBP/catenin antagonists bind, is by far the most divergent region between these two Kat3 coactivators